Molecular Testing for Plasmodium falciparum by Use of Serum or Plasma and Comparison with Microscopy and Rapid Diagnostic Testing in Febrile Nigerian Patients.
Plasmodium nucleic acids have been detected in serum and plasma, but there is little published data describing the diagnostic performance of malaria nucleic acid amplification tests (NAATs) using these specimen types. Previously, our group described a multiplex NAAT for the detection of dengue virus, Leptospira, and Plasmodium species with a callout for P. falciparum (the DLM assay) that demonstrated sensitive detection of P. falciparum from plasma samples during initial evaluation. In this study, we evaluated the sensitivity and specificity of P. falciparum detection in febrile Nigerian patients using the DLM assay, microscopy, and a rapid diagnostic test (BinaxNOW Malaria). Assay performances were compared using a composite reference, which was considered positive if malaria was detected by two or more methods. Serum (n = 182) or plasma (n = 148) from 317 patients was tested; the average sample volume was 70 μl (range, 5 to 300 μl). The sensitivity and specificity of the DLM assay were 97.1% and 93.5%, respectively. The sensitivity of the malaria rapid diagnostic test (98.1%) was similar to that of the DLM assay, and both proved significantly more sensitive than microscopy (79%; P < 0.0001). When analysis was limited to samples with ≥75 μl of serum or plasma, the sensitivity of the DLM assay improved to 99% and specificity was 97.5%. For P. falciparum cases, cycle threshold values in the DLM assay correlated with the parasite density detected by microscopy (Spearman's rank correlation coefficient, P < 0.0001). In conclusion, malaria detection using the DLM assay on serum or plasma is more sensitive than and equal in specificity to microscopy in patients with P. falciparum malaria.
Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.
Jesse J
JJ
Waggoner
Department of Medical Microbiology and Parasitology, University of Lagos College of Medicine, Lagos, Nigeria.
Chika
C
Okangba
Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Alisha
A
Mohamed-Hadley
Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Martina I
MI
Lefterova
Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Niaz
N
Banaei
Department of Medical Microbiology and Parasitology, University of Lagos College of Medicine, Lagos, Nigeria.
Wellington
W
Oyibo
Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA Department of Pathology, Stanford University School of Medicine, Stanford, California, USA bpinsky@stanford.edu.
Benjamin A
BA
Pinsky
D000293:Adolescent; D004269:DNA, Bacterial / Q000097:blood* / Q000235:genetics; D005260:Female; D006801:Humans; D020071:Interspersed Repetitive Sequences / Q000235:genetics; D016778:Malaria, Falciparum / Q000175:diagnosis* / Q000469:parasitology; D008297:Male; D008853:Microscopy / Q000379:methods*; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D009549:Nigeria; D021141:Nucleic Acid Amplification Techniques / Q000379:methods; D010963:Plasmodium falciparum / Q000235:genetics*; D016133:Polymerase Chain Reaction / Q000379:methods; D012337:RNA, Ribosomal, 18S / Q000235:genetics; D012680:Sensitivity and Specificity
D004269:DNA, Bacterial; D012337:RNA, Ribosomal, 18S